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Astrocytes  perform  essential  neuron-supporting  functions  in  the  central  nervous  system  (CNS)  and
their disruption  has  devastating  effects  on neuronal  integrity  in  multiple  neuropathologies.  Although
astrocytes  are  considered  resistant  to  most  pathological  insults,  ischemia  can  result in astrocyte  injury
and  astrocytes  in  postnatal  white  matter  are  particularly  vulnerable.  Metabotropic  glutamate  receptors
(mGluR)  are  neuroprotective  in  ischemia  and  are widely  expressed  by  astrocytes  throughout  CNS  grey
matter, but  their  potential  cytoprotective  role  in  astrocytes  had  not  been  determined.  Here,  we  iden-
tify  functional  expression  of  group  I mGluR  in white  matter  astrocytes  and  demonstrate  their  activation
protects  astrocytes  from  ischemic  damage  in  the  postnatal  mouse  optic  nerve.  Optic  nerve  astrocytes
are  shown  to express  mGluR5  using  immunolabelling  of sections  and  explant  cultures  from  transgenic
reporter  mice  in  which  GFAP  drives  expression  of EGFP.  In addition,  using  Fluo-4  calcium  imaging  in  iso-
lated intact  optic  nerves,  we  show  that the  group  I/II mGluR  agonist  ACPD  and  the  speciﬁc  group  I  mGluR
2+hite matter agonist  DHPG  evoke  glial  Ca signals  that were  signiﬁcantly  inhibited  by the  group  I mGluR  antagonist
AIDA.  A  key ﬁnding  is that  activation  of  group  I mGluR  protects  astrocytes  against  oxygen-glucose  depri-
vation  (OGD)  in  situ,  in isolated  intact  optic  nerves  from  GFAP-EGFP  mice.  This  study  identiﬁes  a  role  for
group  I mGluR  in  protecting  astrocytes  against  ischemia  in  postnatal  white  matter  and  suggests  this  may
be  a strategy  for limiting  damage  in neuropathologies  involving  excitotoxity.
© 2015  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license. Introduction
Astrocytes have diverse and important functions in the pathol-
gy of cerebral ischemia [1]. Although astrocytes may  be less
usceptible than neurons to ischemic damage, astrocyte death is
n important component of ischemia and has detrimental effects
n neuronal survival and integrity [2–5]. The susceptibility of astro-
ytes to ischemia depends on the brain region [6], and astrocytes
n developing white matter may  be particularly vulnerable [5,7,8].
schemia-mediated cytotoxicty involves multiple events, but there
s a key role for raised extracellular glutamate. Glutamate is cen-
ral to white matter pathology [9,10], and is excitoxic for astrocytes
n vitro [11] and in situ in the spinal cord [12]. The cytotoxic effects
f glutamate are mediated largely through AMPA- and NMDA-
ype ionotropic glutamate receptors (iGluR). In contrast, group I
etabotropic GluR (mGluR) have a protective role in neurons and
ligodendrocytes exposed to ischaemic injury [13–15], but astro-
ytes have been neglected in this context. Group I mGluRs (mGluR1
∗ Corresponding author. Tel./fax: +44 0 2392842156.
E-mail address: arthur.butt@port.ac.uk (A.M. Butt).
ttp://dx.doi.org/10.1016/j.ceca.2015.06.010
143-4160/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
and mGluR5) are positively coupled to phospholipase C (PLC)
and inositol triphosphate (InsP3) formation, resulting in release of
Ca2+ from endoplasmic reticulum (ER) intracellular stores. Group
I mGluR have been shown to mediate Ca2+ signals in grey matter
astrocytes [16,17] and regulate synaptic activity at the tripartite
synapse [18]. White matter astrocytes also display glutamate-
mediated Ca2+ signaling [19], although the signiﬁcance of mGluR
and their possible role in the astrocyte response to ischemia was
unknown. In this study, we demonstrate functional expression of
group I mGluR in postnatal white matter astrocytes and show for
the ﬁrst time that they protect astrocytes from ischemia.
2. Materials and methods
2.1. Animals
Mice aged postnatal day (P)8–15 were used throughout and
killed humanely to obtain tissue, in accordance with the UK  Animals
(Scientiﬁc Procedures) Act, 1986. Wild type mice of the C57BL/6
strain were used, or transgenic mice in which the ﬂuorescent
reporter enhanced green ﬂuorescence protein (EGFP) is driven by
the astroglial gene glial ﬁbrillary acidic protein (GFAP) (gift from
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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rank Kirchhoff, University of Saarland, Germany). Brain tissue and
ptic nerves were removed for immunostaining, tissue culture, cal-
ium imaging or ischemia experiments.
.2. Optic nerve explant cultures
Optic nerve explant cultures were prepared as previously
escribed [20]. Brieﬂy, optic nerves from P8 GFAP-EGFP mice
ere placed directly into 50 l dissecting medium consisting of
igh glucose Dulbecco’s Modiﬁed Eagle Medium (DMEM) (Sigma-
5671) containing 10% Fetal Calf Serum (FCS; Life Technologies),
-Glutamine (Sigma) and 0.1% Gentamycin (Life Technologies).
erves were ﬁnely chopped with a scalpel blade and triturated
ith pipettes of decreasing diameter. After adding 50 l dissec-
ing medium, the solution was pipetted onto poly-l-lysine/laminin
oated coverslips (1 nerve per coverslip). After 24 h, the dissecting
edium was replaced with a low serum (0.5%) modiﬁed Botten-
tein and Sato (B&S) medium [21]. Explant cultures were treated
or immunolabelling after 7–10 days in vitro (DIV).
.3. Immunolabelling
Brain tissue and optic nerves from P8-9 GFAP-EGFP mice were
xed with 4% paraformaldehyde (PFA), and explant cultures with
% PFA, all containing 15% picric acid; ﬁxation was for 24 h for
rain tissue, 1 h for optic nerves and 10 min  for explant cultures.
ixed brain and optic nerves were cryoprotected in 30% sucrose at
◦C for 24–48 h and embedded in Cryo-M-Bed (Bright Instruments
ompany Ltd), before rapidly freezing and storage at −80 ◦C until
se. Coronal brain sections and longitudinal optic nerve sections
14 m)  were collected onto Polysine® coated slides (Thermo-
cientiﬁc). Sections and explant cultures were treated the same
ubsequently. A blocking stage was performed by incubation in
0% normal goat (NGS) in phosphate buffered saline (PBS) for 1-2 h,
hen washed 3 times in PBS and incubated overnight with primary
ntibodies in blocking solution containing 0.01% Triton-X-100: rab-
it anti-mGluR5, at 1:1000 (Neuromics); chicken anti-GFAP, at
:500 (Chemicon). Samples were then washed 3 times in PBS and
ncubated with the appropriate secondary antibodies conjugated
ith 568Alexaﬂuor (1:400, Life Technologies). Following immuno-
abelling, coverslips/sections were mounted with Vectasheild®
VectorLabs). Controls were performed in which sections were pre-
bsorbed with antigen peptide overnight prior to incubation in
he primary antibody for mGluR5 and no immunolabelling was
etected in these sections. Images were acquired using a Zeiss
xiovert LSM710 VIS405 confocal microscope, using multichannel
equential scanning, narrow bandwidths, and minimal laser power
nd gain to prevent cross-talk between the channels. Immunola-
elling results are presented as two-dimensional ﬂattened images
f the z-stacks, approximately 10–20 z-sections of <0.75 m thick-
ess, and a colocalization channel was generated to illustrate in the
oxels in which the two channels overlap with the same intensity
Volocity 6.1, Perkin Elmer).
.4. Calcium imaging
Optic nerves from P8-P13 wild type C57BL/6 mice were iso-
ated intact for Fluo-4 calcium imaging, as described previously
19]. In brief, nerves were incubated for 1 h in aCSF contain-
ng 4 M Fluo-4 AM (Molecular Probes); aCSF comprised (in
M)  133 NaCl, 3 KCl, 1.5 CaCl2, 1.2 NaH2PO4, 1.0 MgCl2, 10
-glucose, 10 HEPES, pH 7.3. Loaded nerves were then placed
n a perfusion chamber under a Zeiss LSM 5 Pascal Axioskop
 confocal microscope and continuously perfused with aCSF
ia a multitap system. Nerves were imaged using a 20x/0.50
Ph2 Achroplan water immersion lens objective using excitationium 58 (2015) 423–430
at 488 nm and optical z-sections (7–8 sections at 2–3 m intervals)
were obtained using the Zeiss LSM Image Examiner software (Zeiss,
Germany). Regions of interest (ROI) comprising individual glial cell
bodies were selected and changes in ﬂuorescence intensity above
baseline (F/F) were measured in arbitrary units (AU). The multitap
system allowed rapid turnover of solution bathing the nerve to one
containing pharmacological agents, made up in aCSF to a ﬁnal con-
centration of 100 M (all agents purchased from Tocris): adenosine
triphosphate (ATP); group I/II mGluR agonist ACPD ((±)-1-
Aminocyclopentane-trans-1,3-dicarboxylic acid); selective group
I mGluR agonist DHPG ((RS)-3,5-Dihydroxyphenylglycine); group
I antagonist AIDA ((RS)-1-Aminoindan-1,5-dicarboxylic acid). In
each nerve, a brief pulse (30 s) of ATP (100 M)  was used at the
beginning and end of the experiment to conﬁrm the viability of
the nerve, and in this way  the responses to mGluR agonists could
be compared to the maximal response observed in ATP, in paired
recordings from individual cells [19]. Data were expressed as mean
± SEM, where ‘n’ represents the number of cells, and signiﬁcance
was determined by paired t-tests, using Prism 5.0 (Graphpad).
2.5. Oxygen-glucose deprivation
Optic nerves from P8-11 transgenic GFAP-EGFP mice were iso-
lated intact and immediately placed in oxygenated aCSF at 37 ◦C for
30 min. Controls were incubated for a further 1 h in normal aCSF
containing 10 mM glucose with 95% O2/5% CO2. Oxygen-glucose
deprivation (OGD) was achieved using the method of Fern and
colleagues [22], by incubating nerves for 1 h at 37 ◦C in glucose-
free aCSF (osmolarity was maintained by replacing glucose with
sucrose), and switching the chamber atmosphere to 95%N2/5%CO2.
mGluR agonists ACPD and DHPG (100 M)  were added directly to
the aCSF. At the end of 60 min  normoxia or OGD, nerves were ﬁxed
immediately in 4% PFA for 1 h. Intact nerves were whole-mounted
in vectashield and analysis by confocal microscopy. Images cap-
tured using a Zeiss LSM 710 Metaconfocal microscope, using a
x40 oil immersion lens with high numerical aperture (1.3 nm),
maintaining acquisition parameters constant between samples.
Cells were counted within a constant volume of 20 × 20 m in
the x–y-plane and 15 m in the z-plane, as previously described
[23]. Data were expressed as mean ± SEM, where ‘n’ represents
the number of nerves, and signiﬁcance was  determined by ANOVA
and Newman-Keuls multiple comparison post-hoc analysis, using
Prism 5.0 (Graphpad).
3. Results
3.1. Optic nerve astrocytes express mGluR5
Astroglial expression of group I mGluR5 is well documented in
CNS grey matter, where they are important in synaptic transmis-
sion. Although glutamatergic signaling is also prominent in white
matter, astroglial expression of mGluR was  unresolved, and so we
examined this in transgenic GFAP-EGFP reporter mice. Expression
of mGluR5 by grey matter astrocytes was conﬁrmed in cortical sec-
tions (Fig. 1A–C), and no immunolabelling was  observed in controls
in which sections were preabsorbed with antigen peptide (Fig. 1B,
inset). Prominent colocalization of mGluR5 immunolabelling (red,
Fig. 1B) and EGFP (green, Fig. 1A) was  demonstrated by the gen-
eration of a colocalization channel (Fig. 1C, colocalization appears
yellow and GFAP-EGFP+ astrocyte appears grey), using the neg-
ative controls to set the threshold and determine the voxels in
which the green and red channels are of equal ﬂuorescent intensity.
Similar punctate mGluR5 immunolabelling was  observed in optic
nerve sections (Fig. 1E), some of which colocalized to GFAP-EGFP+
astrocytes (Fig. 1D and G). However, the optic nerve is densely
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Fig. 1. mGluR5 expression in astrocytes. Confocal images of brain sections (A–C), optic nerve sections (D–G) and optic nerve explant cultures (H–J) from GFAP-EGFP mice,
to  identify astrocytes (green) and immunolabelled for mGluR5 (red). (A–C) Cortical section illustrating protoplasmic astrocyte (A, green) and immunolabelling for mGluR5
(B,  red), together with a colocalisation channel, in which voxels with the same intensity in red and green channels appear yellow (C, astrocyte appears grey); inset in (B)
illustrates the absence of mGluR5 immunolabelling in negative controls in which sections were preabsorbed with antigen peptide. (D–G) Optic nerve section illustrating
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f  EGFP and mGluR appears yellow, astrocyte appears grey). (H–J) Optic nerve explan
I,  red), together with the overlay (J, coexpression appears yellow), with evident mG
acked with glia and myelinated axons and it was  difﬁcult to visu-
lize cellular expression of mGluR5, which was  achieved using
ptic nerve explant cultures prepared from P8 GFAP-EGFP reporter
ice (Fig. 1H–J; coexpression appears yellow in Fig. 1J). The results
emonstrate optic nerve astrocytes express mGluR5 on their cell
omata and processes, but to a lower level than is apparent in grey
atter astrocytes.
.2. Group I mGluR evoke calcium signals in optic nerve
strocytes
Stimulation of group I mGluR results in activation of PLC and
nsP3-dependent release of Ca2+ from intracellular stores in hip-
ocampal astrocytes [16,17]. We  examined this in situ in the
solated intact optic nerve from P8-15 mice, using Fluo-4 calcium
maging. The optic nerve contains mainly astrocytes and oligoden-
rocytes (>90% of cells), with minor populations of OPCs (<5%)
nd microglia (<5%) [24]. The bulk of cells that load with Fluo-4
n the intact optic nerve are astrocytes [19,25], which were dis-
inguished from other glia by the size of their somata; astrocytes
ave large somata (>12 m diameter) that are separate from each
ther, whereas oligodendrocytes have small somata (<10 m diam-
ter) that are aligned in rows of 4 or more cells, and OPCs and
icroglia have the smallest somata that are isolated from eachverlay of red and green channels (F) and the colocalisation channel (G,  colocalisation
re illustrating GFAP-EGFP+ astrocyte (H, green) and mGluR5 immunocytochemistry
immunostaining on the astrocyte cell somata and processes. Scale Bars = 20 m.
other by 20–50 m [24,26]. Recordings from cells with the features
of astrocytes displayed robust and reproducible [Ca2+]i elevations
in response to ATP (100 M),  as reported previously, which was
used to conﬁrm glial cell viability at the beginning and end of the
experiments [19]. Paired recordings in optic nerve glia demon-
strate that individual cells respond to ATP, glutamate and ACPD,
an agonist at both group I and II mGluR (Fig. 2A). The false colour
images illustrate a typical response, with a mean relative potency of
ATP>glutamate>ACPD (Fig. 2A; n = 41 cells from 5 nerves bar graph,
p < 0.05, paired t-tests); in some cells the response to glutamate and
ACPD was greater than for ATP (Fig. 2A, lower traces).
Paired recordings from Fluo-4 AM loaded optic nerves show that
glia responded to the speciﬁc group I agonist DHPG (100 M)  with
a mean maximum rise in [Ca2+]i that was  signiﬁcantly greater than
ACPD in the same cells (Fig. 2B; n = 13 cells from 4 nerves; p < 0.01,
paired t-test). Notably, DHPG often evoked multiple Ca2+ spikes,
characteristic of astroglial Ca2+ ‘oscillations’ (Fig. 2B, lower traces)
[17]. The glial response to ACPD was signiﬁcantly decreased in the
presence of the speciﬁc group I mGluR antagonist AIDA (100 M)
(Fig. 3; n = 16 cells from 4 nerves; p < 0.001, paired t-test). The
response to AIDA was variable and in some cells it almost com-
pletely blocked the ACPD response (Fig. 3A, B); this did not appear
to be related to cell type and overall AIDA signiﬁcantly inhibited
glutamate-evoked Ca2+ signals in optic nerve glia. In addition, some
426 I. Vanzulli, A.M. Butt / Cell Calcium 58 (2015) 423–430
Fig. 2. Group I mGluR evoke raised calcium in optic nerve glia. Optic nerves were isolated intact and loaded with Fluo-4 to analyse the response of glial cells to the group
I/II  agonist ACPD (A) and speciﬁc group I mGluR agonist DHPG (B). (A) Confocal images of Fluo-4 ﬂuorescence intensity illustrated in rainbow false colour (upper panel) and
representative traces of individual glia (lower left-hand panel) illustrate the response of glial cells to ATP, glutamate and ACPD (all at 100 M and administered for 30 s).
The  bar graph shows the mean response (± SEM) expressed in arbitrary units (n = 41 cells from 5 nerves). (B) Confocal images of Fluo-4 ﬂuorescence intensity illustrated in
rainbow false colour (upper panel) and representative traces of individual glial cells (lower left-hand panel) illustrate that the selective group I mGluR agonist DHPG evokes
a  greater response than ACPD (both at 100 M,  applied for 30 s) and triggers Ca2+ oscillations. The bar graph shows the mean response (± SEM) expressed in arbitrary units
(n  = 13 cells from 4 nerves). Scale bars = 10 m.  *p < 0.05, **p < 0.01, ***p < 0.01, paired t-tests.
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Fig. 3. Group I mGluR antagonist AIDA signiﬁcantly decreases glial calcium signals. Optic nerves were isolated intact and loaded with Fluo-4 to analyse the effect of the
speciﬁc group I antagonist AIDA on the response of glial cells to the group I/II agonist ACPD. (A, B) Confocal images of changes in Fluo-4 ﬂuorescence intensity (A, rainbow
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he  response to ACPD. (C) In many cells, Ca2+ oscillations persisted following block
igniﬁcantly less in the presence of AIDA, expressed in arbitrary units (n = 16 cells fr
ells displayed persistent Ca2+ oscillations following group I mGluR
lockade (Fig. 3C), which has also been reported in hippocampal
strocytes in situ [17].
.3. Group I mGluR protect astrocytes from ischemia in situ in the
ostnatal mouse optic nerve
Group I mGluR protect neurons from ischemia and their
unctional expression in the optic nerve suggests they may
lay a similar role in postnatal white matter astrocytes, which
re highly vulnerable to ischemic damage. We  examined this
n situ in the isolated intact optic nerve from GFAP-EGFP mice
ged P8-12, using the oxygen-glucose deprivation (OGD) model
f ischemia (Fig. 4). Optic nerves were exposed to normoxic
r acute OGD conditions for 60 min  and analysed immedi-
tely, without reperfusion. The results demonstrate that optic
erve astrocytes are highly susceptible to ischemia, with a
0% loss after 60 min  OGD compared to normoxic controls
Fig. 4A, B, E; p < 0.001, ANOVA and Newman-Keuls multiplemost completely blocked the response to APCD, but in others only partially blocked
f group I mGluR. (D) Bar graph showing the mean response (± SEM) to ACPD was
 nerves). ***p < 0.001, paired t-test. Scale bar in A = 10 m.
comparison post-hoc analysis). Incubation with ACPD or the spe-
ciﬁc group I agonist DHPG almost completely protected astrocytes
against ischemia, their number being signiﬁcantly greater in ACPD
and DHPG compared to OGD (Fig. 2A and C; p < 0.001, ANOVA and
Newman-Keuls multiple comparison post-hoc analysis), and not
signiﬁcantly different than normoxic controls (p > 0.05, ANOVA).
4. Discussion
White matter astrocytes are highly susceptible to ischemia-
hypoxia, with potentially devastating consequences for CNS
function [2–5]. There is evidence that group I mGluR are protec-
tive against brain ischemia and excitotoxicty in postnatal white
matter in vivo [27], in situ in brain slices [28,29], and in vitro in
cultured neurons and astrocytes [30,31]. Speciﬁcally, activation of
mGluR5 has been shown to protect against neuronal loss in fore-
brain ischemia [32] and white matter damage in a rodent model of
periventricular leukomalacia (PVL), the main cause of cerebral palsy
and death in premature babies [27]. Here, we  demonstrate that
428 I. Vanzulli, A.M. Butt / Cell Calc
Fig. 4. Activation of group I mGluR protects postnatal optic nerve astrocytes from
ischemia. Optic nerves from P9 GFAP-EGFP reporter mice were maintained for 1 h in
normoxic conditions with glucose (A), or exposed to 1 h oxygen-glucose deprivation
(OGD), in aCSF (B), in the presence of the group I/II agonist ACPD (C), or the speciﬁc
group I agonist DHPG (D). (A–D) Representative images of GFAP-EGFP+ astrocytes
in isolated intact optic nerves; scale bars = 50 m.  (E) Bar graph of the mean (±
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oEM) number of GFAP-EGFP cells in constant ﬁelds of view (FOV; n = 5 nerves per
xperimental group; ***p < 0.001, ANOVA with Newman–Keuls multiple comparison
ost-hoc analysis).
hite matter astrocytes express mGluR5 and activation of mGluR5
rotects astrocytes from ischemic injury postnally in situ in the
ouse optic nerve. The results of our study indicate that target-
ng mGluR5 in astrocytes could contribute to an overall strategy
or protecting CNS integrity and function in ischemia and other
europathologies involving excitoxicity.
Our immunohistochemical evidence of mGluR5 expression in
strocytes is in agreement with studies that identiﬁed mRNA
or mGluR5, but not mGluR1, in hippocampal astrocytes isolated
rom young and adult rats [33,34]. Astroglial immunolabelling for
GluR1 was not successful in our hands, but has been detected
y immunocytochemistry in 10% of cultured astrocytes prepared
rom spinal cord [35] and in a subpopulation of reactive astro-
ytes in multiple sclerosis lesions [36]. Our results indicated the
verall level and pattern of mGluR immunostaining appearedium 58 (2015) 423–430
similar in the cortex and optic nerve, although mGluR5 expres-
sion appeared greater in grey matter astrocytes compared to white
matter astrocytes. Calcium imaging conﬁrmed the functionality of
group I mGluR in optic nerve glia identiﬁed as astrocytes on the
basis of their large isolated somata [19,26]; since mGluR1 were not
detected it is likely this is due mainly to activation of mGluR5. In
grey matter astrocytes, activation of mGluR triggers their release
of glutamate and other gliotransmitters, which can evoke synap-
tic responses in neighbouring neurons and glia [37,38]. Notably,
glutamate is an important signaling molecule in CNS white mat-
ter [9]. Astrocyte processes contact axons at nodes of Ranvier [39]
and respond to glutamate released during axonal electrical activity
[19]. This would activate astroglial mGluR and potentially trigger
their release of neurotransmitters, including glutamate, adenosine
and ATP, which propagate intercellular Ca2+ signals between astro-
cytes and other glia [19,40], to potentially modulate axonal activity
and myelination [9]. Moreover, activation of mGluR stimulates
the astroglial homeostatic functions of potassium and glutamate
uptake [41], which would serve to couple astroglial homeostatic
functions to axonal activity and help maintain axonal conduc-
tion, which is essential along long white matter tracts, such as
the spinal cord, and for integrated cognitive function throughout
the brain.
Activation of group I mGluR elicited Ca2+ oscillations in optic
nerve glia, which is likely to be mediated by mGluR5, since
mGluR1 tend to evoke single-peaked responses [42–44]. However,
astrocytes can display various pattern of response, transient or
oscillatory, depending on the species, brain regions and age of the
animal [34,45,46]. In cultured astrocytes, activation of mGluR5 with
ACPD mediates calcium oscillations via PKC phosphorylation [47].
In our experiments, DHPG evokes oscillatory responses, consistent
with in situ studies on hippocampal astrocytes [16,17]. ACPD does
not evoke currents in white matter oligodendrocytes in brain slices
[48] although it elicits a rise in [Ca2+]I in cultured oligodendrocyte
progenitor cells (OPCs) [49].
Astrocytes in the postnatal optic nerve were highly susceptible
to ischemia, with a striking halving of their numbers after 60 min
OGD, consistent with ischemia-induced apoptosis in astrocytes [3]
and OGD-induced loss of immature astrocytes in the postnatal optic
nerve [25,50]. A key ﬁnding of our study is that activation of group
I mGluR completely protected astrocytes in situ, which supports
evidence that ACPD attenuates white matter loss in ischemia [14].
The inﬂux of Ca2+ is one of the most signiﬁcant events in ischemia
and Ca2+ overload results in mitochondrial dysfunction leading to
death [51]. In neonatal rat optic nerve, an important cause of astro-
cyte cell death is the run-down of Na+–K+ pumps and Na+–K+–Cl−
cotransport (NKCC1) during hypoxia/ischemia, which results in a
rise in [Na+]i and reversal of the Na+–Ca2+ exchanger (NCX) [52,53].
In addition, membrane depolarization and subsequent opening
of voltage-operated calcium channels (VOCC) results in a rise in
astrocyte [Ca2+]i initially through T-type VOCC within the ﬁrst
10 minutes of ischemia, followed by L-type Ca2+ channels [25].
Interestingly, we show that activation of group I mGluR in astro-
cytes evokes a rise in [Ca2+]i, but this clearly does not induce cell
death and is cytoprotective for astrocytes in ischemia. It is pos-
sible that mGluR activation alters NCX, NKCC or VOCC activity
in astrocytes. Furthermore, increased extracellular glutamate is a
major cause of excitotoxic cell death and activation of astroglial
group I mGluR may  indirectly reduce cell death by preventing a
loss of astroglial glutamate transporters and thereby maintaining
glutamate removal from the extracellular space [54]. Moreover,
activated astrocytes upregulate the expression of group I/II mGluR
[55] and speciﬁcally mGluR5 [56,57]. These indirect effects are
likely to be important in ischemia, particularly over the longer term,
but an important cytoprotective effect of mGluR5 in astrocytes
is likely to be direct protection against OGD-induced apoptosis,
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F-B pathways [58–61].
In conclusion, this study demonstrates that group I mGluR are
ytoprotective for postnatal astrocytes in ischemia. Glutamate is an
mportant signaling molecule in CNS white matter physiology and
athology [9,10]. Our results provide new evidence that astroglial
GluR are important in these signaling cascades and represents
 potential therapeutic strategy for limiting damage to postnatal
hite matter in pathologies that involve ischemia and excitoxicity.
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